Search Results - "Laverman, G. D"

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities by Gant, C. M, Oosterwijk, M. M, Binnenmars, S. H, Navis, G. J, Haverkate, H, Bakker, S. J. L, Laverman, G. D

“…Abstract Objective Pharmacological inhibition of the renin-angiotensin-aldosterone-system (RAASi) is the cornerstone of hypertension treatment, renoprotection…”
Get full text

Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial by Kwakernaak, A J, Roksnoer, L C, Lambers Heerspink, H J, van den Berg-Garrelds, I, Lochorn, G A, van Embden Andres, J H, Klijn, M A, Kobori, H, Danser, A H J, Laverman, G D, Navis, G J

“…The combination of weight excess and hypertension significantly contributes to cardiovascular risk and progressive kidney damage. An unfavorable renal…”
Get full text

Optimal dosing of renin-angiotensin-aldosterone system blockers for renal protection: a solved issue? by Laverman, G. D, Bakker, S. J. L, Navis, G. J

Get full text

A spangled colon by RAGHOO, R, LAVERMAN, G. D, WOITTIEZ, A. J. J, VAN DEN HOUT, J. H. W, DE VRIES, P. A. M

Get full text

A 33-year-old man presenting with rectal ulceration and nephrotic syndrome by BOSLOOPER, K, LAVERMAN, G. D, VAN DER HEIDE, H, TIEBOSCH, A. T. M. G, JANSSEN, W. M. T

Get full text

Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands by van Bon, A C, Blauw, H, Jansen, T J P, Laverman, G D, Urgert, T, Geessink-Mennink, J, Mulder, A H, Out, M, Groote Veldman, R, Onvlee, A J, Schouwenberg, B J J W, Vermeulen, M A R, Diekman, M J M, Gerding, M N, van Wijk, J P H, Klaassen, M, Witkop, M, DeVries, J H

“…Management of insulin administration for intake of carbohydrates and physical activity can be burdensome for people with type 1 diabetes on hybrid closed-loop…”
Get full text

Concordance of dietary sodium intake and concomitant phosphate load: Implications for sodium interventions by Humalda, J.K, Keyzer, C.A, Binnenmars, S.H, Kwakernaak, A.J, Slagman, M.C.J, Laverman, G.D, Bakker, S.J.L, de Borst, M.H, Navis, G.J

“…Abstract Background and aims Both a high dietary sodium and high phosphate load are associated with an increased cardiovascular risk in patients with chronic…”
Get full text

Circulating matrix γ‐carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome by CRANENBURG, E. C. M., VAN SPAENDONCK‐ZWARTS, K. Y., BONAFE, L., MITTAZ CRETTOL, L., RÖDIGER, L. A., DIKKERS, F. G., VAN ESSEN, A. J., SUPERTI‐FURGA, A., ALEXANDRAKIS, E., VERMEER, C., SCHURGERS, L. J., LAVERMAN, G. D.

“…Background and objectives: Matrix γ‐carboxyglutamate protein (MGP), a vitamin K‐dependent protein, is recognized as a potent local inhibitor of vascular…”
Get full text

Increasing evidence of tick-borne encephalitis (TBE) virus transmission, the Netherlands, June 2016 by Weststrate, Adriaan Cg, Knapen, Daan, Laverman, Gozewijn D, Schot, Bart, Prick, Jan Jw, Spit, Silke A, Reimerink, Johan, Rockx, Barry, Geeraedts, Felix

“…We present a case of endemic tick-borne encephalitis (TBE) occurring in June 2016 in the eastern part of the Netherlands in an area where a strain of TBE…”
Get full text

Time for a comeback of NSAIDs in proteinuric chronic kidney disease? by Vogt, L, Laverman, G D, Navis, G

“…Before the introduction of renin-angiotensin-aldosterone system (RAAS) inhibitors in the 1980s, non-steroidal anti-inflammatory drugs (NSAIDs) were the only…”
Get full text

The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria by MAHMOODI, B. K., MULDER, A. B., WAANDERS, F., SPRONK, H. M. H., MULDER, R., SLAGMAN, M. C. J., VOGT, L., NAVIS, G., TEN CATE, H., KLUIN‐NELEMANS, H. C., LAVERMAN, G. D.

“…Background: Overt proteinuria is a strong risk factor for thromboembolism, owing to changes in the levels of various coagulation proteins and urinary…”
Get full text

Bilateral dacryoadenitis as a presenting symptom of an extra-ocular disease by van den Wildenberg, M J, Laverman, G D, de Vries, P A M

Get full text

Prolonged hypocalcaemia after pamidronate infusion in Riedel's thyroiditis associated hypoparathyroidism by Boumans, D, de Vries, P A M, Rikken, N E T, Laverman, G D

Get full text

Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria by Laverman, Gozewijn D., Henning, Robert H., de Jong, Paul E., Navis, Gerjan, de Zeeuw, Dick

“…Although the antiproteinuric response to antihypertensive treatment is the main predictor of renoprotective efficacy in long-term renal disease, to date,…”
Get full text

Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? by Vogt, L, Kocks, M J A, Laverman, G D, Navis, G

“…Data of numerous clinical trials show that lowering of blood pressure is prerequisite for reducing the rate of renal function loss in chronic renal disease…”
Get more information

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial by Slagman, Maartje C J, Waanders, Femke, Hemmelder, Marc H, Woittiez, Arend-Jan, Janssen, Wilbert M T, Lambers Heerspink, Hiddo J, Navis, Gerjan, Laverman, Gozewijn D

“…Objective To compare the effects on proteinuria and blood pressure of addition of dietary sodium restriction or angiotensin receptor blockade at maximum dose,…”
Get full text

Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction by Vogt, Liffert, Laverman, Gozewijn D., Dullaart, Robin P. F., Navis, Gerjan

Get full text

Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials by Holtkamp, Frank A., de Zeeuw, Dick, de Graeff, Pieter A., Laverman, Gozewijn D., Berl, Tom, Remuzzi, Giuseppe, Packham, David, Lewis, Julia B., Parving, Hans-Henrik, Lambers Heerspink, Hiddo J.

“…Aims The long-term cardioprotective effect of angiotensin receptor blockers (ARBs) is associated with the short-term lowering of its primary target blood…”
Get full text

Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects by SLAGMAN, Maartje C. J, KWAKERNAAK, Arjan J, YAZDANI, Saleh, LAVERMAN, Gozewijn D, DEN BORN, Jaap Van, TITZE, Jens, NAVIS, Gerjan

“…Recent experimental findings demonstrate vascular endothelial growth factor C (VEGF-C)-mediated water-free storage of salt in the interstitium, which prevents…”
Get full text

Performance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease by Tent, Hilde, Waanders, Femke, Krikken, Jan A, Heerspink, Hiddo J Lambers, Stevens, Lesley A, Laverman, Gozewijn D, Navis, Gerjan

“…Chronic kidney disease (CKD) typically extends over decades. Longitudinal monitoring of kidney function in CKD is thus of great importance. Here, we…”
Get full text